Kemin and DSM promote eye health at lutein event

- Last updated on GMT

Professor Paul Bernstein
Professor Paul Bernstein

Related tags: Age-related macular degeneration, Zeaxanthin, Lutein, Macular degeneration, European food safety authority

Kemin Industries and DSM Nutritional Products have hosted an event exploring the latest lutein science and regulatory state of play.

Held last week in Munich, Germany, invited scientists spoke on biomarker development, bioavailability of differing lutein forms and the latest research linking the carotenoid alon with zeaxanthin to reducing eye conditions like age-related macular degeneration (AMD).

Patrick Coppens from the Brussels-based consultancy, EAS, outlined the state of play with lutein-based health claims in the European Union, after last year’s negative opinion from the European Food Safety Authority (EFSA).

“Our focus is to understand mechanistically how and why the macular pigment carotenoids are concentrated in the human foveal region at the highest concentrations found anywhere in the human body,”​ said one of the speakers, Professor Paul Bernstein from the Moran Eye Center at the University of Utah.

Related topics: Suppliers

Related news

Follow us

Featured Events

View more

Products

View more

Webinars